Accurate measurement of tumour response during and after neoadjuvant chemotherapy NAC is important and may influence treatment decisions in invasive breast cancer patients. Breast MRI forms the gold standard but is more burdensome time consuming and costly. In this study response measurement was done with 3-D ultrasound by Automated Breast Volume Scanner ABVS and compared to breast MRI. Moreover patient satisfaction with both techniques was compared. Three-dimensional ultrasonography of the breast; An adequate replacement for MRI in neoadjuvant chemotherapy tumour response evaluation? - RESPONDER trial.